title: Profiling the structural determinants of heteroarylnitrile scaffold-based derivatives as falcipain-2 inhibitors by in silico methods.
abstract: Evidence indicates that cysteine protease falcipain-2 plays essential role in malaria parasites; therefore the potent and selective inhibitors of falcipain-2 may be therapeutically useful drugs for treatment of various forms of malaria parasite plasmodium. In order to understand the structure-activity correlation of falcipain-2 inhibitors, a set of ligand- and receptor-based 3D-QSAR models were, for the first time, developed in the present work employing Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Index Analysis (CoMSIA) for 240 promising molecules. Based on the ligand-based alignment, an optimal 3D-QSAR model was obtained with good predictive power of Q(2) = 0.501, R(2)(ncv) = 0.890, SEE = 0.282, F = 153.522 and R(2)(pred) = 0.768. And the contour maps intuitively suggest where to modify the molecular structures in order to improve the binding affinity. In addition, docking analysis and molecular dynamics simulation (MD) study were also carried out on the dataset with purpose of exploring the detailed binding modes of ligand in the falcipain-2 binding pocket. The combination of docking analysis and MD simulation shows that Gly83, Trp43 and Ala175 which formed several H-bonds are crucial for falcipain-2 inhibitors. The analysis of the best QSAR model reveals the structural features related to the activity, and provides an insight into molecular mechanisms of inhibition and possible modification of the molecules for better activity.
authors: Department of Materials Sciences and Chemical Engineering, Dalian University of Technology, Dalian 116023, Liaoning, China. yanli@dlut.edu.cn
authors: Jinghui
authors: J
authors: Wang
authors: Yan
authors: Y
authors: Li
authors: Yinfeng
authors: Y
authors: Yang
authors: Shuwei
authors: S
authors: Zhang
authors: Ling
authors: L
authors: Yang
mesh_terms: D003546:Cysteine Endopeptidases / Q000737:chemistry / Q000378:metabolism*; D015853:Cysteine Proteinase Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D062105:Molecular Docking Simulation; D009570:Nitriles / Q000737:chemistry / Q000494:pharmacology; D010963:Plasmodium falciparum / Q000737:chemistry / Q000187:drug effects / Q000201:enzymology*; D021281:Quantitative Structure-Activity Relationship
chemical_list: D015853:Cysteine Proteinase Inhibitors; D009570:Nitriles; D003546:Cysteine Endopeptidases; C416224:falcipain 2